Yu F L, Grunberger D
Cancer Res. 1976 Oct;36(10):3629-33.
This study attempts to identify the site(s) of action of N-hydroxy-2-acetylaminofluorene (N-OH-AAF) in relation to its inhibition of rat hepatic nuclear RNA synthesis. Two hr after N-OH-AAF injection (3 mg/100 g body weight), rat hepatic nuclear synthesis and nucleolar RNA synthesis in vitro were inhibited by 60 and 80%, respectively. When total nuclear RNA polymerases were solubilized and assayed in the presence of alpha-amanitin (3.2 mug/ml), only alpha-amanitin-sensitive activity was reduced (50%) by N-OH-AAF. Diethylamino-ethyl-Sephadex column chromatography confirmed this finding and further demonstrated that RNA polymerase II was the activity selectively inhibited. Since N-OH-AAF dramatically inhibited nucleolar RNA synthesis but had little effect on RNA polymerase I activity, per se, we therefore concluded that, in addition to its direct inhibitory effect on the enzymic function of RNA polymerase II, N-OH-AAF must also cause impairment of the nucleolar DNA template function.
本研究旨在确定N-羟基-2-乙酰氨基芴(N-OH-AAF)对大鼠肝细胞核RNA合成抑制作用的作用位点。注射N-OH-AAF(3mg/100g体重)两小时后,大鼠肝细胞核合成及体外核仁RNA合成分别被抑制60%和80%。当在α-鹅膏蕈碱(3.2μg/ml)存在的情况下对总核RNA聚合酶进行溶解和测定时,只有α-鹅膏蕈碱敏感活性被N-OH-AAF降低(50%)。二乙氨基乙基-葡聚糖凝胶柱层析证实了这一发现,并进一步表明RNA聚合酶II是被选择性抑制的活性。由于N-OH-AAF显著抑制核仁RNA合成,但本身对RNA聚合酶I活性影响很小,因此我们得出结论,除了对RNA聚合酶II的酶功能有直接抑制作用外,N-OH-AAF还必定会导致核仁DNA模板功能受损。